Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 8Phase 3 6Phase 4 4Phase 1/2 3Phase NA 1

Status

Completed 6Unknown 3Active not recruiting 2

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 1Gynecologic 1

Conditions

Papillomavirus Infections 2Herpes Zoster 2Whooping Cough 1Uterine Cervical Neoplasms 1Tetanus 1Neoplasms, Glandular and Epithelial 1Meningitis 1Hematologic Neoplasms 1Diphtheria 1Condylomata Acuminata 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Completed × Vaccines × Clear all
NCT04965350 2023-04-13

Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females

Shanghai Zerun Biotechnology Co.,Ltd

Phase 3 Completed
1,100 enrolled

Papillomavirus Infections

NCT01798056 2021-05-13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

GlaxoSmithKline

Phase 3 Completed
237 enrolled 20 charts

Herpes Zoster

NCT01254630 2019-09-30

V212-011

Merck Sharp & Dohme LLC

Phase 3 Completed
5,305 enrolled 20 charts
Other hematologic neoplasm

Herpes Zoster, Hematologic Neoplasms

NCT01984697 2018-08-08

V503-010

Merck Sharp & Dohme LLC

Phase 3 Completed
1,518 enrolled 44 charts

Papillomavirus Infections

NCT00501137 2015-04-10

BCGov-01

University of British Columbia

Phase 3 Completed
830 enrolled
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT00325130 2015-03-12

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Merck Sharp & Dohme LLC

Phase 3 Completed
1,042 enrolled 26 charts

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

Data powered by HemOnc (CC BY 4.0) Colophon âš¡